Pacer Advisors’s Precigen PGEN Stock Holding History

Pacer Advisors’s Portfolio PGEN Stock Details PGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$19K	Buy	+3,289	New	+$14.2K	﹤0.01%	2262
2021 Q2	–	Sell	-8,708	Closed	-$60K	–	1511
2021 Q1	$60K	Buy	8,708 +5,202	+148%	+$44K	﹤0.01%	1418
2020 Q4	$36K	Buy	+3,506	New	+$22.7K	﹤0.01%	1445
2018 Q4	–	Sell	-9,413	Closed	-$162K	–	915
2018 Q3	$162K	Buy	+9,413	New	+$140K	0.01%	1049
2018 Q1	–	Sell	-2,650	Closed	-$31K	–	1106
2017 Q4	$31K	Buy	+2,650	New	+$39.5K	﹤0.01%	1063
2017 Q3	–	Sell	-9,282	Closed	-$224K	–	1238
2017 Q2	$224K	Buy	9,282 +1,930	+26%	+$42.3K	0.02%	959
2017 Q1	$146K	Buy	7,352 +1,251	+21%	+$27.9K	0.02%	990
2016 Q4	$147K	Buy	6,101 +572	+10%	+$15.9K	0.02%	962
2016 Q3	$154K	Buy	5,529 +695	+14%	+$18.4K	0.02%	909
2016 Q2	$118K	Buy	+4,834	New	+$137K	0.02%	962

Other funds holding PGEN

PCM

Patient Capital Management Baltimore, Maryland $3.05B AUM 42.09% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

BCM

Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Pacer Advisors's PGEN Position: Q2 2026 in Review

Pacer Advisors opened a new position in Precigen (PGEN) in Q2 2026: 3,289 shares worth $19K. The stake represents ﹤0.01% of the portfolio and ranks #2262 among its holdings. This is a return to the name: Pacer Advisors previously reported a position in PGEN as recently as Q1 2021.

Pacer Advisors first reported a position in PGEN in Q2 2016 and has held it in 10 quarters since. The position peaked at $224K in Q2 2017. 211 funds tracked by Wall St. Rank hold PGEN as of Q2 2026.

Pacer Advisors held 3,289 shares of Precigen worth $19K as of Q2 2026.
Precigen was a new Pacer Advisors position in Q2 2026.
Precigen made up ﹤0.01% of Pacer Advisors's portfolio in Q2 2026, its #2262 holding.
Pacer Advisors first reported a position in Precigen in Q2 2016 and has held it in 10 quarters since.
Pacer Advisors's Precigen position peaked at $224K in Q2 2017.
211 funds tracked by Wall St. Rank held Precigen as of Q2 2026.

Based on Pacer Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.